文献速递肝病消化道肿瘤与早癌

受体相互作用蛋白激酶3缺失通过趋化因子(C-X-C基序)配体1-趋化因子(C-X-C基序)受体2轴招募髓源性抑制细胞至肝细胞癌

Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.
PubMed 文献 · Hepatology · 2019-07-17

研究发现肝细胞癌患者中RIP3表达下降,且与髓源性抑制细胞(MDSC)积聚相关,RIP3是肝细胞癌患者的预后因素。RIP3敲低通过磷酸化P65Ser536并促进其核转位增加肝癌细胞CXCL1表达,经CXCL1-CXCR2轴诱导MDSC募集,促进免疫逃逸和肝癌生长;CXCR2拮抗剂可抑制MDSC趋化及RIP3敲除小鼠肝癌生长。

要点

  • 肝细胞癌患者RIP3表达下降,与MDSC积聚相关,RIP3是预后因素。
  • RIP3敲低增加MDSC、减少IFN-γ+CD8+T细胞,促进免疫逃逸和肝癌生长。
  • RIP3敲低经CXCL1-CXCR2轴诱导MDSC募集,CXCR2拮抗剂可抑制MDSC趋化和肝癌生长。

核心结论

  • RIP3缺失是引导MDSC归巢至肝细胞癌并促进CXCL1/CXCR2诱导的MDSC趋化、从而促进肝癌免疫逃逸和进展的重要因素;阻断CXCL1-CXCR2趋化因子轴可能为抑制RIP3缺陷型肝细胞癌进展提供免疫治疗途径。

研究设计与样本

  • 研究观察了肝细胞癌患者中RIP3表达与MDSC积聚及预后的关系,并在免疫健全小鼠中通过RIP3敲低和敲除模型探讨机制。

主要发现

  • 肝细胞癌患者中RIP3表达下降,且与MDSC积聚相关,RIP3是肝细胞癌患者的预后因素。
  • RIP3敲低导致肝癌组织中MDSC增加、IFN-γ+CD8+T细胞减少,从而促进免疫逃逸和肝癌生长。
  • RIP3敲低通过磷酸化P65Ser536并促进磷酸化P65Ser536核转位,增加肝癌细胞CXCL1表达。
  • RIP3敲低通过CXCL1-CXCR2轴诱导MDSC募集。
  • CXCR2拮抗剂显著抑制RIP3敲除小鼠中MDSC趋化和肝癌生长。

临床怎么用

  • 原文结论提出阻断CXCL1-CXCR2趋化因子轴可能为抑制RIP3缺陷型肝细胞癌进展提供免疫治疗途径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Receptor-interacting protein kinase 3 (RIP3) is the core regulator that switches cell death from apoptosis to necrosis. However, its role in tumor immunity is unknown. In this study, decreased RIP3 expression was observed in patients with hepatocellular carcinoma (HCC), which correlates with myeloid-derived suppressor cell (MDSC) accumulation. Moreover, RIP3 is a prognosis factor for patients with HCC. We further found that RIP3 knockdown results in an increase of MDSCs and a decrease of interferon gamma-positive (IFN-γ+ ) cluster of differentiation 8-positive (CD8+ ) tumor-infiltrating lymphocytes (IFN-γ+ CD8+ T cells) in hepatoma tissues, thus promoting immune escape and HCC growth in immunocompetent mice. By phosphorylating P65Ser536 and promoting phosphorylated P65Ser536 nuclear translocation, RIP3 knockdown increases the expression of chemokine (C-X-C motif) ligand 1 (CXCL1) in HCC cells. RIP3 knockdown induces MDSC recruitment through the CXCL1-chemokine (C-X-C motif) receptor 2 (CXCR2) axis. Furthermore, a CXCR2 antagonist substantially suppresses MDSC chemotaxis and HCC growth in RIP3 knockout mice. Conclusion: RIP3 deficiency is an essential factor directing MDSC homing to HCC and promoting CXCL1/CXCR2-induced MDSC chemotaxis to facilitate HCC immune escape and HCC progression; blocking the CXCL1-CXCR2 chemokine axis may provide an immunological therapeutic approach to suppress progression of RIP3 deficiency HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Li YM, Liu ZY, Wang JC, et al. Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis. Hepatology. 2019. PMID: 31021443. doi:10.1002/hep.30676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。